New Drug Delivery System Doubles Mesothelioma Survival

A new method for delivering cancer-fighting drugs directly into mesothelioma tumors has been shown to more that double mesothelioma survival in a new animal study. Surgeons, pathologists, biomedical engineers and chemists from Boston University and Harvard Medical School used specially-formulated expanding nanoparticles to deliver high doses of the drug paclitaxel into mice with malignant mesothelioma. By loading the drug into nanoparticles that expand in the … Continue reading New Drug Delivery System Doubles Mesothelioma Survival »

New Mesothelioma Immunotherapies Target Key Protein

The cell-surface glycoprotein mesothelin is poised to be a key part of several new immunotherapy approaches for the treatment of malignant pleural mesothelioma, a treatment-resistant cancer caused by asbestos. A team of top mesothelioma researchers with the National Cancer Institute’s Center for Cancer Research recently published their analysis of several ongoing studies of therapies that target mesothelin in mesothelioma treatment. Mesothelin’s Relationship to Mesothelioma Mesothelin is … Continue reading New Mesothelioma Immunotherapies Target Key Protein »

Study Finds Chemotherapy Maximizes Odds of Mesothelioma Survival

A large US study of mesothelioma patients confirms what other studies have suggested: Mesothelioma patients who have chemotherapy live longer than those who don’t, and multimodal therapy is the best way to improve overall mesothelioma survival. The study utilized data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database and included 1,625 Medicare patients with a diagnosis or either peritoneal or pleural … Continue reading Study Finds Chemotherapy Maximizes Odds of Mesothelioma Survival »

Mesothelioma Treatment News: Novel Immunotherapy Drug Featured at International Symposium

A promising immunotherapy drug made from a deactivated cold virus has cleared another hurdle on its way to becoming a viable new treatment for malignant mesothelioma. Scientists with the Norway-based company that makes ONCOS-102 presented their most recent mesothelioma research data to colleagues at a symposium hosted by the International Society of Stem Cell Research and the European Society of Gene and Cell Therapy in October. … Continue reading Mesothelioma Treatment News: Novel Immunotherapy Drug Featured at International Symposium »

Mesothelioma Growth Slowed by Breast Cancer Drug

A drug most often associated with the treatment and prevention of breast cancer may offer a new way to treat pleural mesothelioma, too. A new study conducted by Ireland’s Royal College of Surgeons and published in the medical journal Anticancer Research focuses on tamoxifen as a novel mesothelioma therapy. How Tamoxifen Works Tamoxifen helps fight breast cancer and protect high-risk women from getting it by … Continue reading Mesothelioma Growth Slowed by Breast Cancer Drug »

Novel Treatment for Malignant Mesothelioma with Cholesterol Drugs

There is new evidence that a class of medicines normally used to reduce high cholesterol may have a role to play in the fight against malignant pleural mesothelioma. A new study conducted by researchers at Nagoya University in Japan suggests that mesothelioma cells with a certain kind of genetic mutation may be susceptible to treatment with a statin drug. What are Statin Drugs? Statin drugs … Continue reading Novel Treatment for Malignant Mesothelioma with Cholesterol Drugs »

Experimental Treatment Targets Pleural Mesothelioma with Compound in Red Wine

The question of how to make chemotherapy more effective in the treatment of malignant mesothelioma is one that has plagued cancer researchers for years. Now, a group of Korean doctors believe they may be closer to an answer. Scientists at Soonchunhyang University in Cheonan, Korea were the first to study the mesothelioma-fighting power of a chemical in red wine called resveratrol back in 2012 and have … Continue reading Experimental Treatment Targets Pleural Mesothelioma with Compound in Red Wine »

New Treatment Strategy Could Make Mesothelioma More Responsive to Chemotherapy

Researchers in Japan have taken another important step toward creating a novel therapeutic strategy for malignant pleural mesothelioma, a highly treatment-resistant and deadly form of lung cancer. Following up on research they conducted earlier this year, doctors at Tokushima University’s Institute of Health Biosciences successfully boosted the effectiveness of chemotherapy and prolonged mesothelioma survival in mice by manipulating their RNA. RNA and Malignant Mesothelioma Ribonucleic … Continue reading New Treatment Strategy Could Make Mesothelioma More Responsive to Chemotherapy »

Mesothelioma Survival May Depend on the Timing of Chemotherapy

People with one of the rarer subtypes of mesothelioma may live longer if they have chemotherapy as soon as possible after their mesothelioma surgery. That is the finding of an international team of mesothelioma researchers studying the timing of mesothelioma chemotherapy. Their new report has just been published in the prestigious journal, Lung Cancer. Chemotherapy for Mesothelioma Most patients diagnosed with malignant mesothelioma will have chemotherapy during … Continue reading Mesothelioma Survival May Depend on the Timing of Chemotherapy »

New Drug Combination May Extend Mesothelioma Survival

A drug derived from the eggs of leopard frogs may offer new hope for people with intractable malignant mesothelioma – especially if the drug is administered in combination with a malaria drug called dihydroartemisinin (DHA). A newly-published Chinese report suggests that the combination has anti-tumor effects on non-small cell lung cancer and malignant mesothelioma not seen with conventional cancer drugs. A Winning Drug Combination? Onconase … Continue reading New Drug Combination May Extend Mesothelioma Survival »